SCHEMBL29567208

SCHEMBL29567208

CC(C)c1ccccc1-c1cc(Oc2cccc(N3CCN(C)CC3)c2F)nc(NS(=O)(=O)c2cnn(C)c2)n1

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 10/20 0.41
▸ HTR7 P34969 9/20 0.41
▸ HTR1A P08908 8/20 0.41
▸ DRD2 P14416 4/20 0.41
▸ HTR2A P28223 7/20 0.36
▸ HTR2C P28335 3/20 0.34
▸ BRD4 O60885 2/20 0.34
▸ TNK2 Q07912 1/20 0.33
▸ ADRA1D P25100 1/20 0.33
▸ ADRA1A P35348 1/20 0.33
▸ ADRA1B P35368 1/20 0.33
▸ DRD3 P35462 1/20 0.33
▸ APAF1 O14727 1/20 0.33
▸ MITF O75030 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309753 1.00 HTR6 (0.41) HTR6HTR7HTR1ADRD2HTR2A
SCHEMBL29567213 0.91 DRD2 (0.41) HTR6HTR7HTR1ADRD2HTR2A
SCHEMBL26808351 0.88 HTR1A (0.40) HTR6HTR7HTR1ADRD2HTR2A
SCHEMBL26808374 0.86 HTR1A (0.44) HTR6HTR7HTR1ADRD2HTR2A
SCHEMBL29566472 0.86 BRD4 (0.39) HTR6HTR7HTR1AHTR2ABRD4
SCHEMBL26809820 0.86 BRD4 (0.39) HTR6HTR7HTR1AHTR2ABRD4
SCHEMBL29566934 0.85 HTR7 (0.39) HTR6HTR7HTR1ADRD2HTR2A
SCHEMBL24310020 0.85 HTR7 (0.39) HTR6HTR7HTR1ADRD2HTR2A
SCHEMBL26808353 0.83 HTR1A (0.39) HTR6HTR7HTR1ADRD2HTR2A
SCHEMBL24309255 0.81 DRD2 (0.36) HTR6HTR7HTR1ADRD2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback